Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways

Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pharmacology and experimental therapeutics 2012-11, Vol.343 (2), p.468-478
Hauptverfasser: Jirkovsky, Eduard, Popelová, Olga, Kriváková-Stanková, Pavla, Vávrová, Anna, Hroch, Milos, Hasková, Pavlína, Brcáková-Dolezelová, Eva, Micuda, Stanislav, Adamcová, Michaela, Simůnek, Tomás, Cervinková, Zuzana, Gersl, Vladimír, Sterba, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 478
container_issue 2
container_start_page 468
container_title The Journal of pharmacology and experimental therapeutics
container_volume 343
creator Jirkovsky, Eduard
Popelová, Olga
Kriváková-Stanková, Pavla
Vávrová, Anna
Hroch, Milos
Hasková, Pavlína
Brcáková-Dolezelová, Eva
Micuda, Stanislav
Adamcová, Michaela
Simůnek, Tomás
Cervinková, Zuzana
Gersl, Vladimír
Sterba, Martin
description Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.
doi_str_mv 10.1124/jpet.112.198358
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_jpet_112_198358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22915767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EgvJYs0P-gbR-xHmwQxUvCYkNrCNnbBNXqV3Zjkq-iN8kocBq7mjunMVB6JqSJaUsX212Os1pSeuKi-oILahgNCOU8GO0IISxjItCnKHzGDeE0Dwv-Ck6Y6ymoizKBfpad8E7C1i61AUJI_TWaQwyKOuT_7Rg03iLt77XMPQyTD2FzeAgWe9kP62yH6ONeG9Th42HIWLvsBug11PbSEg-YB3Gie6twiwLupdJq78T-yFubfLQeaeCnaCt9R_a6Rm7k6nbyzFeohMj-6ivfucFen-4f1s_ZS-vj8_ru5cMWF2mrCZVVRempTWlZZEbxrnIaWnatiyVULSVopKG0bYqRS0MgMqNYKxqCeO5BOAXaHXgQvAxBm2aXbBbGcaGkmZW3szK59QclE8fN4eP3dButfrv_znm36RYgj0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Jirkovsky, Eduard ; Popelová, Olga ; Kriváková-Stanková, Pavla ; Vávrová, Anna ; Hroch, Milos ; Hasková, Pavlína ; Brcáková-Dolezelová, Eva ; Micuda, Stanislav ; Adamcová, Michaela ; Simůnek, Tomás ; Cervinková, Zuzana ; Gersl, Vladimír ; Sterba, Martin</creator><creatorcontrib>Jirkovsky, Eduard ; Popelová, Olga ; Kriváková-Stanková, Pavla ; Vávrová, Anna ; Hroch, Milos ; Hasková, Pavlína ; Brcáková-Dolezelová, Eva ; Micuda, Stanislav ; Adamcová, Michaela ; Simůnek, Tomás ; Cervinková, Zuzana ; Gersl, Vladimír ; Sterba, Martin</creatorcontrib><description>Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>DOI: 10.1124/jpet.112.198358</identifier><identifier>PMID: 22915767</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Anthracyclines - toxicity ; Antibiotics, Antineoplastic - toxicity ; Cell Nucleus - drug effects ; Cell Nucleus - metabolism ; Daunorubicin - pharmacology ; Echocardiography ; Glutathione - metabolism ; Heart Diseases - chemically induced ; Heart Diseases - metabolism ; Heart Function Tests ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; Lipid Peroxidation - drug effects ; Male ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Myocardium - pathology ; NF-E2-Related Factor 2 - biosynthesis ; Oxidative Stress - drug effects ; Rabbits ; Real-Time Polymerase Chain Reaction ; Survival ; Transcription Factors - metabolism ; Troponin T - metabolism</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2012-11, Vol.343 (2), p.468-478</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</citedby><cites>FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22915767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jirkovsky, Eduard</creatorcontrib><creatorcontrib>Popelová, Olga</creatorcontrib><creatorcontrib>Kriváková-Stanková, Pavla</creatorcontrib><creatorcontrib>Vávrová, Anna</creatorcontrib><creatorcontrib>Hroch, Milos</creatorcontrib><creatorcontrib>Hasková, Pavlína</creatorcontrib><creatorcontrib>Brcáková-Dolezelová, Eva</creatorcontrib><creatorcontrib>Micuda, Stanislav</creatorcontrib><creatorcontrib>Adamcová, Michaela</creatorcontrib><creatorcontrib>Simůnek, Tomás</creatorcontrib><creatorcontrib>Cervinková, Zuzana</creatorcontrib><creatorcontrib>Gersl, Vladimír</creatorcontrib><creatorcontrib>Sterba, Martin</creatorcontrib><title>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.</description><subject>Animals</subject><subject>Anthracyclines - toxicity</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>Cell Nucleus - drug effects</subject><subject>Cell Nucleus - metabolism</subject><subject>Daunorubicin - pharmacology</subject><subject>Echocardiography</subject><subject>Glutathione - metabolism</subject><subject>Heart Diseases - chemically induced</subject><subject>Heart Diseases - metabolism</subject><subject>Heart Function Tests</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Myocardium - pathology</subject><subject>NF-E2-Related Factor 2 - biosynthesis</subject><subject>Oxidative Stress - drug effects</subject><subject>Rabbits</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Survival</subject><subject>Transcription Factors - metabolism</subject><subject>Troponin T - metabolism</subject><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EgvJYs0P-gbR-xHmwQxUvCYkNrCNnbBNXqV3Zjkq-iN8kocBq7mjunMVB6JqSJaUsX212Os1pSeuKi-oILahgNCOU8GO0IISxjItCnKHzGDeE0Dwv-Ck6Y6ymoizKBfpad8E7C1i61AUJI_TWaQwyKOuT_7Rg03iLt77XMPQyTD2FzeAgWe9kP62yH6ONeG9Th42HIWLvsBug11PbSEg-YB3Gie6twiwLupdJq78T-yFubfLQeaeCnaCt9R_a6Rm7k6nbyzFeohMj-6ivfucFen-4f1s_ZS-vj8_ru5cMWF2mrCZVVRempTWlZZEbxrnIaWnatiyVULSVopKG0bYqRS0MgMqNYKxqCeO5BOAXaHXgQvAxBm2aXbBbGcaGkmZW3szK59QclE8fN4eP3dButfrv_znm36RYgj0</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Jirkovsky, Eduard</creator><creator>Popelová, Olga</creator><creator>Kriváková-Stanková, Pavla</creator><creator>Vávrová, Anna</creator><creator>Hroch, Milos</creator><creator>Hasková, Pavlína</creator><creator>Brcáková-Dolezelová, Eva</creator><creator>Micuda, Stanislav</creator><creator>Adamcová, Michaela</creator><creator>Simůnek, Tomás</creator><creator>Cervinková, Zuzana</creator><creator>Gersl, Vladimír</creator><creator>Sterba, Martin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20121101</creationdate><title>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</title><author>Jirkovsky, Eduard ; Popelová, Olga ; Kriváková-Stanková, Pavla ; Vávrová, Anna ; Hroch, Milos ; Hasková, Pavlína ; Brcáková-Dolezelová, Eva ; Micuda, Stanislav ; Adamcová, Michaela ; Simůnek, Tomás ; Cervinková, Zuzana ; Gersl, Vladimír ; Sterba, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c297t-908896fb1911764f2335417fbb77d5d1ba58af21b87595fccd4f5228b0234acc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Anthracyclines - toxicity</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>Cell Nucleus - drug effects</topic><topic>Cell Nucleus - metabolism</topic><topic>Daunorubicin - pharmacology</topic><topic>Echocardiography</topic><topic>Glutathione - metabolism</topic><topic>Heart Diseases - chemically induced</topic><topic>Heart Diseases - metabolism</topic><topic>Heart Function Tests</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Myocardium - pathology</topic><topic>NF-E2-Related Factor 2 - biosynthesis</topic><topic>Oxidative Stress - drug effects</topic><topic>Rabbits</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Survival</topic><topic>Transcription Factors - metabolism</topic><topic>Troponin T - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jirkovsky, Eduard</creatorcontrib><creatorcontrib>Popelová, Olga</creatorcontrib><creatorcontrib>Kriváková-Stanková, Pavla</creatorcontrib><creatorcontrib>Vávrová, Anna</creatorcontrib><creatorcontrib>Hroch, Milos</creatorcontrib><creatorcontrib>Hasková, Pavlína</creatorcontrib><creatorcontrib>Brcáková-Dolezelová, Eva</creatorcontrib><creatorcontrib>Micuda, Stanislav</creatorcontrib><creatorcontrib>Adamcová, Michaela</creatorcontrib><creatorcontrib>Simůnek, Tomás</creatorcontrib><creatorcontrib>Cervinková, Zuzana</creatorcontrib><creatorcontrib>Gersl, Vladimír</creatorcontrib><creatorcontrib>Sterba, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jirkovsky, Eduard</au><au>Popelová, Olga</au><au>Kriváková-Stanková, Pavla</au><au>Vávrová, Anna</au><au>Hroch, Milos</au><au>Hasková, Pavlína</au><au>Brcáková-Dolezelová, Eva</au><au>Micuda, Stanislav</au><au>Adamcová, Michaela</au><au>Simůnek, Tomás</au><au>Cervinková, Zuzana</au><au>Gersl, Vladimír</au><au>Sterba, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>343</volume><issue>2</issue><spage>468</spage><epage>478</epage><pages>468-478</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>Anthracycline anticancer drugs (e.g., doxorubicin or daunorubicin) can induce chronic cardiotoxicity and heart failure (HF), both of which are believed to be based on oxidative injury and mitochondrial damage. In this study, molecular and functional changes induced by chronic anthracycline treatment with progression into HF in post-treatment follow-up were analyzed with special emphasis on nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) pathways. Chronic cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg, weekly for 10 weeks), and the animals were followed for another 10 weeks. Echocardiography revealed a significant drop in left ventricular (LV) systolic function during the treatment with marked progression to LV dilation and congestive HF in the follow-up. Although daunorubicin-induced LV lipoperoxidation was found, it was only loosely associated with cardiac performance. Furthermore, although LV oxidized glutathione content was increased, the oxidized-to-reduced glutathione ratio itself remained unchanged. Neither Nrf2, the master regulator of antioxidant response, nor the majority of its target genes showed up-regulation in the study. However, down-regulation of manganese superoxide dismutase and NAD(P)H dehydrogenase [quinone] 1 were observed together with heme oxygenase 1 up-regulation. Although marked perturbations in mitochondrial functions were found, no induction of PGC1α-controlled mitochondrial biogenesis pathway was revealed. Instead, especially in the post-treatment period, an impaired regulation of this pathway was observed along with down-regulation of the expression of mitochondrial genes. These results imply that global oxidative stress need not be a factor responsible for the development of anthracycline-induced HF, whereas suppression of mitochondrial biogenesis might be involved.</abstract><cop>United States</cop><pmid>22915767</pmid><doi>10.1124/jpet.112.198358</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 2012-11, Vol.343 (2), p.468-478
issn 0022-3565
1521-0103
language eng
recordid cdi_crossref_primary_10_1124_jpet_112_198358
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Anthracyclines - toxicity
Antibiotics, Antineoplastic - toxicity
Cell Nucleus - drug effects
Cell Nucleus - metabolism
Daunorubicin - pharmacology
Echocardiography
Glutathione - metabolism
Heart Diseases - chemically induced
Heart Diseases - metabolism
Heart Function Tests
Heart Ventricles - drug effects
Heart Ventricles - metabolism
Lipid Peroxidation - drug effects
Male
Mitochondria, Heart - drug effects
Mitochondria, Heart - metabolism
Myocardium - pathology
NF-E2-Related Factor 2 - biosynthesis
Oxidative Stress - drug effects
Rabbits
Real-Time Polymerase Chain Reaction
Survival
Transcription Factors - metabolism
Troponin T - metabolism
title Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20anthracycline%20cardiotoxicity:%20molecular%20and%20functional%20analysis%20with%20focus%20on%20nuclear%20factor%20erythroid%202-related%20factor%202%20and%20mitochondrial%20biogenesis%20pathways&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Jirkovsky,%20Eduard&rft.date=2012-11-01&rft.volume=343&rft.issue=2&rft.spage=468&rft.epage=478&rft.pages=468-478&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/10.1124/jpet.112.198358&rft_dat=%3Cpubmed_cross%3E22915767%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22915767&rfr_iscdi=true